Spinocerebellar Ataxia Type 34
Description
Spinocerebellar ataxia type 34 (SCA34) is a subtype of autosomal dominant cerebellar ataxia type I (ADCA type I; see this term), characterized by papulosquamous, ichthyosiform plaques on the limbs appearing shortly after birth and later manifestations including progressive ataxia, dysarthria, nystagmus and decreased reflexes.
Clinical Features
Top most frequent phenotypes and symptoms related to Spinocerebellar Ataxia Type 34
- Ataxia
- Nystagmus
- Strabismus
- Spasticity
- Hyperreflexia
- Dysarthria
- Gait disturbance
- Cerebellar atrophy
- Hyporeflexia
- Babinski sign
And another 28 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Spinocerebellar Ataxia Type 34 Is also known as erythrokeratodermia with ataxia, sca34, spinocerebellar ataxia and erythrokeratodermia.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Spinocerebellar Ataxia Type 34 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Baylor Miraca Genetics Laboratories (United States).
RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)
View the complete list with 612 more genes
Specificity
1 %
Genes
100 % |
![]() By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RPGR, TIMP3, BEST1, C1QTNF5, ELOVL4, RP1L1, CDH3, RAX2, IMPG2, HMCN1, CNGB3, CTNNA1, MFSD8, DRAM2, EFEMP1, ABCA4, FBLN5, FSCN2, GUCA1B, IMPG1 , (...)
View the complete list with 4 more genes
Specificity
5 %
Genes
100 % |
![]() By Genetic Services Laboratory University of Chicago (United States).
BCS1L, RTN2, SACS, SCN1A, SCN2A, SCN8A, SCO1, SDHA, SDHD, SLC16A2, SLC17A5, SLC19A2, SLC1A3, SLC20A2, SLC2A1, SLC6A1, SLC9A1, SLC9A6, SNAP25, SOD1 , (...)
View the complete list with 457 more genes
Specificity
1 %
Genes
100 % |
![]() By Institute for Human Genetics University Clinic Freiburg (Germany).
ELOVL4
Specificity
100 %
Genes
100 % |
![]() By Laboratory of genome diagnostics Academic Medical Center, University of Amsterdam (Netherlands).
ELOVL4
Specificity
100 %
Genes
100 % |
![]() By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
ELOVL4
Specificity
100 %
Genes
100 % |
![]() By CGC Genetics (Portugal).
ELOVL4
Specificity
100 %
Genes
100 % |
![]() By CGC Genetics (Portugal).
SACS, SLC1A3, SPTBN2, TTPA, VAMP1, VLDLR, CACNA1A, CACNB4, ELOVL4, ABHD12, APTX, TGM6, COQ8A, SYNE1, TDP1, TTBK2, CCDC88C, ELOVL5, SYT14, PLEKHG4 , (...)
View the complete list with 24 more genes
Specificity
3 %
Genes
100 % |
You can get up to 43 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM MESH ORPHANET Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1 CYANOSIS, TRANSIENT NEONATAL; TNCY CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO; CRS5